Cargando…
Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive.
Subcutaneous and intracranial VMDk tumours were treated with photodynamic therapy (PDT) using a new sensitiser, m-THPP. Subcutaneous tumours were highly sensitive to PDT but intracranial tumours were much more resistant, requiring a 30-fold increase in sensitiser dose to produce equivalent levels of...
Autores principales: | Lindsay, E. A., Berenbaum, M. C., Bonnett, R., Thomas, D. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971766/ https://www.ncbi.nlm.nih.gov/pubmed/1997101 |
Ejemplares similares
-
The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy
Publicado: (1996) -
The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.
por: Lilge, L., et al.
Publicado: (1996) -
Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue
por: Lilge, L, et al.
Publicado: (2000) -
Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man.
por: Gilson, D., et al.
Publicado: (1988) -
Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours.
por: Lowdell, C. P., et al.
Publicado: (1993)